Literature DB >> 17642021

An efficient test protocol for identification of a limited, sensitive frequency test range for early detection of ototoxicity.

Nancy E Vaughan1, Stephen A Fausti, Stephen Chelius, David Phillips, Wendy Helt, James A Henry.   

Abstract

A primary focus of research at the National Center for Rehabilitative Auditory Research (NCRAR) has been to develop methodology for rapid and efficient early detection of ototoxicity. It has been shown that an individualized, limited frequency range can be identified, which is sensitive to early ototoxic changes in the auditory system. In this study, a rapid identification protocol for identifying the uppermost target frequency within this sensitive range of ototoxicity (SRO) was investigated. In 36 of 42 ears, the target frequency found with the rapid identification protocol was the same as that found with the full-frequency baseline testing. Where differences occurred, target frequencies obtained by the two methods did not differ by more than one-half octave. This rapid identification protocol results in considerable time savings in ototoxicity monitoring, which will result in the capability to include more patients in a monitoring program.

Entities:  

Mesh:

Year:  2002        PMID: 17642021

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  8 in total

1.  Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.

Authors:  Johnnie K Bass; Jie Huang; Arzu Onar-Thomas; Kay W Chang; Shaum P Bhagat; Murali Chintagumpala; Ute Bartels; Sridharan Gururangan; Tim Hassall; John A Heath; Geoffrey McCowage; Richard J Cohn; Michael J Fisher; Giles Robinson; Alberto Broniscer; Amar Gajjar; James G Gurney
Journal:  Pediatr Blood Cancer       Date:  2013-11-01       Impact factor: 3.167

2.  Development and validation of a cisplatin dose-ototoxicity model.

Authors:  Marilyn F Dille; Debra Wilmington; Garnett P McMillan; Wendy Helt; Stephen A Fausti; Dawn Konrad-Martin
Journal:  J Am Acad Audiol       Date:  2012 Jul-Aug       Impact factor: 1.664

3.  Evaluation of audiometric threshold shift criteria for ototoxicity monitoring.

Authors:  Dawn Konrad-Martin; Kenneth E James; Jane S Gordon; Kelly M Reavis; David S Phillips; Gene W Bratt; Stephen A Fausti
Journal:  J Am Acad Audiol       Date:  2010-05       Impact factor: 1.664

4.  Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study.

Authors:  Marilyn F Dille; Dawn Konrad-Martin; Frederick Gallun; Wendy J Helt; Jane S Gordon; Kelly M Reavis; Gene W Bratt; Stephen A Fausti
Journal:  J Am Acad Audiol       Date:  2010-06       Impact factor: 1.664

5.  Proposed comprehensive ototoxicity monitoring program for VA healthcare (COMP-VA).

Authors:  Dawn Konrad-Martin; Kelly M Reavis; Garnett McMillan; Wendy J Helt; Marilyn Dille
Journal:  J Rehabil Res Dev       Date:  2014

Review 6.  Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions.

Authors:  Dawn Konrad-Martin; Gayla L Poling; Angela C Garinis; Candice E Ortiz; Jennifer Hopper; Keri O'Connell Bennett; Marilyn F Dille
Journal:  Int J Audiol       Date:  2017-11-20       Impact factor: 2.117

7.  Extended high-frequency thresholds in college students: effects of music player use and other recreational noise.

Authors:  Colleen G Le Prell; Christopher Spankovich; Edward Lobariñas; Scott K Griffiths
Journal:  J Am Acad Audiol       Date:  2013-09       Impact factor: 1.664

Review 8.  Ototoxicity: A Challenge in Diagnosis and Treatment.

Authors:  Purushothaman Ganesan; Jason Schmiedge; Vinaya Manchaiah; Simham Swapna; Subhashini Dhandayutham; Purushothaman Pavanjur Kothandaraman
Journal:  J Audiol Otol       Date:  2018-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.